Glenn Joseph B Mendoza M D - NY Rockland, Suffern 10901

Glenn Joseph B Mendoza M D entered the industry of Internal Medicine Doctors in 2010 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 621111, which describes it as a Internal Medicine Doctors. For further clarification, the SIC classifies this business under the code 8011 and described it as a Internal Medicine Doctors. The business provides service to the B2C market.

To acquire more information, please contact Glenn J Mendoza by calling (845) 368-5104 during business hours. You can also write to the business’ Single Location at 255 Lafayette Avenue, Suffern, New York NY 10901. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Glenn Joseph B Mendoza M D
Representative: Glenn J Mendoza
Place of Business: 255 Lafayette Avenue, Suffern, NY 10901
Contact Number: (845) 368-5104
Type of Service: Internal Medicine Doctors
SIC Number: 8011
NAICS Number: 621111
Locality: Single Location
Market Type: B2C (Business to Consumer)
Began: 2010
Income/Year: $100.000 to $499.999
Laborers: 1 to 4
Share This Company:

Glenn Joseph B Mendoza M D is a company operating from Rockland, New York providing professional Internal Medicine Doctors and relevant B2C variables. It was founded in 2010 and registered with the SIC code 8011 as Internal Medicine Doctors, and with the NAICS code 621111 as Internal Medicine Doctors.

With a current employee count of 1 to 4, Glenn Joseph B Mendoza M D has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Glenn J Mendoza at (845) 368-5104 for related queries, or to locate its Single Location using the coordinates 41.112117,-74.133661.

The Single Location can also be found at the street address 255 Lafayette Avenue in Suffern, New York 10901 and can be engaged online through the company website at , the company Twitter , and Facebook page .